Revenue from pharma tests, enterprise sales, and other customers in the range of $15 to $16 million; Revenue from population sequencing is expected to be zero due to completion of the prior VA MVP task order
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter